The TB Europe Coalition will host a series of webinars exploring the impact of COVID-19 on TB research and development. The first one will be held on 28 September 2020.

Aidspan: Global Fund Observer

Completing the six months of treatment for standard drug-susceptible tuberculosis (DS-TB) can be hard. Apart from side effects associated with the medicines, people may feel better after a month or two and be tempted to stop taking the treatment. Maintaining treatment adherence is even harder for drug-resistant TB (DR-TB) since the medicines have more serious side effects and treatment can last as long as two years.

A new global AIDS Strategy is currently being developed by UNAIDS.

Shortening carbohydrates in the bacterial cell wall makes them more vulnerable to certain drugs.

The World Health Organization and the Russian Federation are organizing an official UN General Assembly virtual side event on 23 September 2020, Progress and multisectoral action towards achieving global targets to end TB.

Though it may be associated with the past in popular culture, tuberculosis (TB) is still the world’s most fatal infectious disease, killing an estimated 1.5 million people each year.

An article published in the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases journal examined the worldwide effects of COVID-19 pandemic on TB services for the period January–April 2020.

GENEVA, 14 September 2020 − A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic.

In this new coronavirus-affected world, hunger may be India’s next health crisis.